L-Lysine, N2-[N-[[5-[[4,6-dideoxy-4-(methylamino)-3-O-β-D-xylopyranosyl-β-D-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo[a]naphthacen-2-yl]carbonyl]-D-alanyl]-, (5S-trans)- (9CI)

CAS No.
148676-94-2
Chemical Name:
L-Lysine, N2-[N-[[5-[[4,6-dideoxy-4-(methylamino)-3-O-β-D-xylopyranosyl-β-D-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo[a]naphthacen-2-yl]carbonyl]-D-alanyl]-, (5S-trans)- (9CI)
Synonyms
L-Lysylpradimicin A;L-Lysine, N2-[N-[[5-[[4,6-dideoxy-4-(methylamino)-3-O-β-D-xylopyranosyl-β-D-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo[a]naphthacen-2-yl]carbonyl]-D-alanyl]-, (5S-trans)- (9CI)
CBNumber:
CB210244957
Molecular Formula:
C46H56N4O19
Molecular Weight:
968.96
MDL Number:
MFCD01716198
MOL File:
148676-94-2.mol

L-Lysine, N2-[N-[[5-[[4,6-dideoxy-4-(methylamino)-3-O-β-D-xylopyranosyl-β-D-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo[a]naphthacen-2-yl]carbonyl]-D-alanyl]-, (5S-trans)- (9CI) Properties

Boiling point 1230.8±65.0 °C(Predicted)
Density 1.61±0.1 g/cm3(Predicted)
pka 3.16±0.10(Predicted)

L-Lysine, N2-[N-[[5-[[4,6-dideoxy-4-(methylamino)-3-O-β-D-xylopyranosyl-β-D-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo[a]naphthacen-2-yl]carbonyl]-D-alanyl]-, (5S-trans)- (9CI) Preparation Products And Raw materials

Raw materials

Preparation Products

L-Lysine, N2-[N-[[5-[[4,6-dideoxy-4-(methylamino)-3-O-β-D-xylopyranosyl-β-D-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo[a]naphthacen-2-yl]carbonyl]-D-alanyl]-, (5S-trans)- (9CI) Suppliers

Global( 1)Suppliers
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc.
+1-781-999-5354 support@targetmol.com United States 19973 58
Supplier Advantage
TargetMol Chemicals Inc.
58
L-Lysine, N2-[N-[[5-[[4,6-dideoxy-4-(methylamino)-3-O-β-D-xylopyranosyl-β-D-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo[a]naphthacen-2-yl]carbonyl]-D-alanyl]-, (5S-trans)- (9CI) L-Lysylpradimicin A 148676-94-2 C46H56N4O19